S Ul-lfuTlary A novel subset ofT ceils characterized by the expression of an invariant T cell antigen receptor (TC1L) encoded by V0t24J~xQ gene segments was investigated in patients with systemic sclerosis (SSc). Polymerase chain reaction analysis demonstrated that the Vot24 TClL repertoire was selectively used in CD4-CD8-double-negative T cells both in patients and in healthy individuals, while almost all families of TCR.Vot were expressed in single-positive T cell fractions. The Vor + double-negative T cells were increased by approximately fivefold in patients. However, sequence analysis clearly showed significant differences in the Vo~24 TC1L repertoire dominating in patients and healthy donors. In healthy individuals, the invariant Vot24JoLQ was expanded and comprised 20-50% of the total TCR-ot, while their selective reduction was observed in SSc patients who also showed expansion of invariant Vex24 TCR other than Vot24JcxQ. Analogous to murine invariant V~14JoL281 TC1L, these results suggest that T cells with invariant V&24JotQ TCR would function as regulatory T cells, whereas T cells bearing other invariant Vex24 TCR in SSc patients could be autoaggressive T cells in nature. Recent studies by Porcelli et al. (6) and Dellabona et al. (7, 8) indicate that the invariant Vcx24J~xQ sequence is preferentially expressed on DN ot/]3 T cells from healthy individuals. The homology of the nucleotide sequences is found to be 75% in the V0t24 and 90% in the CDR3 regions compared with murine Vo~24 TCR (9). Therefore, the human V&24 sequence is a homologue of murine V&14 TCP,. Another striking similarity to murine invariant V~14 T cells is that human peripheral DN T cells also express a limited TCR.-[3 repertoire including V [32, V[38, VI311, 10) . Interestingly, the decrease in invariant Vod4Jo~281 TCR expression in autoimmune prone mice correlates with disease development. It is thus likely that Vot14 § NK T cells play a role in the regulation ofautoimmune disease development.
A ccumulative evidence demonstrates that there are novel T cell subsets in the thymus characterized by their expression of cell-surface phenotypes of NK1.1 and TC1L (1) (2) (3) (4) . This population belongs to either the double-negative (DN) CD4-CD8-or single-positive (SP) CD4+CD8 -thymocytes but is apparently distinct from conventional T cells and NK cells having the germ line configuration of TC1L genes. Recently, NK T cells have been found to be composed of a relatively large fraction of peripheral T cells comprising 5% of splenic T cells and 40% of bone marrow T cells (4) . The most characteristic feature of NK T cells is that the majority bear an invariant TCP, encoded by V0d4 and Jot281 gene segments with a one-base N region (4, 5) . Thus, invariant Vod4 TC1L is a marker for NK T cells. Moreover, NK T cells express a limited TCR V[~ repertoire, including V]38, V]37, and V]32 (5) .
Recent studies by Porcelli et al. (6) and Dellabona et al. (7, 8) indicate that the invariant Vcx24J~xQ sequence is preferentially expressed on DN ot/]3 T cells from healthy individuals. The homology of the nucleotide sequences is found to be 75% in the V0t24 and 90% in the CDR3 regions compared with murine Vo~24 TCR (9) . Therefore, the human V&24 sequence is a homologue of murine V&14 TCP,. Another striking similarity to murine invariant V~14 T cells is that human peripheral DN T cells also express a limited TCR.-[3 repertoire including V[32, V[38, VI311, and V[313 (6) (7) (8) 10) . Interestingly, the decrease in invariant Vod4Jo~281 TCR expression in autoimmune prone mice correlates with disease development. It is thus likely that Vot14 § NK T cells play a role in the regulation ofautoimmune disease development.
Analogous to murine invariant Vc~14 T cells, we investigated invariant Ve~24Jo~Q TCR expression in patients with autoimmune diseases, such as systemic sclerosis (SSc). Surprisingly, invariant Vc~24 + TCR. other than voL24joLQ were dominant in SSc patients. However, invariant VoL24Jo~Q TCR were undetectable in patients, while 20-50% of TCR. expressed in healthy individuals were invariant voL24JotQ TCR.. The results indicate that T cells bearing invariant Vo~24JotQ function as regulatory T cells, while T cells with other invariant VoL24 TCP, are likely to be autoaggressive in patients.
Materials and Methods
Study Subjects. Four patients diagnosed with SSc (11) were evaluated during the swelling phase of SSc. Three disease-free subjects were also examined as controls. All patients and healthy subjects were of Japanese ancestry and were recruited from the Chiba University Hospital. ) using PE-anti-CD4 plus anti-CD8 mAbs. The yields of DN and SP T cells were 10 s and 10 6, respectively. The purity of fractionated DN samples was confirmed by PCF( with CD4 or CD8 primers (see Fig. 1 C) .
Preparation of RNA and PCR. Total R N A (0.1-10 i.Lg) was prepared using Isogen (Nippon Gene Co. Ltd., Tokyo, Japan) from sorted DN a/J3 T or SP et/[3 T cells, cDNA synthesis and P C R were described elsewhere (12) . Briefly, first-strand cDNAs were synthesized with oligo(dT) primer using 0.1-1 bLg of total RNA. P C R was performed with 21 different Vot and Cot primers at 95~ for 1.5 min for denaturation, 62~ for 1.0 min for annealing, and 72~ for 1.0 rain for extension, for 30 cycles on a DNA thermal cycler (Perkin-Elmer Corp., Norwalk, CT). The P C R products were hybridized with a 32p-labeled Cot probe of 155 bp in length (13) . The sequences of the Vet and Cot primers were published previously (6, 14) .
For confirmation of the purity of enriched samples, the cDNA from sorted DN ~x/[3 T cells was amplified by P C R with CD4 and CD8tx primers (15) , and hybridized with the 32P-labeled EcoKI fragment of the human CD4 gene (16) or the PstI/HincII fragment of the human CD8Ot gene (17) . The CD4 or CD8 cDNA (1 ng) was used as a positive control.
Quantitation of Va2 4 + D N T Cells from SSc Patients and Healthy Subjects. The relative amounts of Vet24 + DN T cells in PBL
were measured by quantitative PCK. R N A was prepared from the sorted DN population derived from 107 of PBL T cells from three SSc patients and four healthy subjects, cDNAs (10 -6 diluted) were used for P C R with primers for Vot24 and Ca. For the standardization curve, Vot24 + cDNAs were serially diluted (corresponding to 0.01-10 pg DNA) and subjected to PCIK with Vot24 and Cot primers. P C R products were hybridized with a 32p-labeled Cot probe, and the intensities of the bands were quantitated by an automated densitometer (Fujix BAS2000; Fujifilm I & I Co., Ltd., Tokyo),
Cloning and Sequencing of cDNAs Encoding TCR Vot Genes.
Vet24 + cDNAs from DN ot/13 T cells were amplified by primers with an Ecot~I restriction site for Vot24
). DNA fragments with the expected size after digestion of P C K products with EcoRI were ligated to M13mp19 plasmids and sequenced by the dye primer method.
Plaque Hybridization. The Vot24 + T C R cDNA libraries were generated by P C R using R N A from the DN population with primers for the Vot24 and Cot. Recombinant plaques were transferred from DYT plates to a nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany) and were hybridized either with a Vet24 probe ( 5 ' -C T C A G C G A T T C A G C C T C C T A C -3 ' ) or a 53-bp JotQ probe (5'-CAACCCTGGGGAGGCTATAC-3' for 5'-JotQ and 5'-AGGCCAGACAGTCAACTGAG-3' for 3'-JotQ).
Statistical Analysis. The statistical significance of the results was determined using the X2-test. (Fig. 1 B) . The purity of the fractionated D N samples was confirmed by reverse transcription-PCR with CD4 or CD8 primers ( Fig. 1 C) , and the TCRVo~ repertoire was then analyzed. As shown in Fig. 2 , almost all families of TCRV~x expression were observed in SP T cell fractions. Although individual VIx gene expression varied in each sample, no significant difference was observed between SSc patients and healthy individuals. O n the other hand, very restricted TCRVcr expression was noted in the D N T cell population. The only Vo~ repertoire detected was Vc124, and in some cases VoL24 and Vo~23. Other TCRVci expression was below the level of detection by D N A blot analysis even with longer exposures (Fig. 2) . The results indicate that the VoL24 T C R repertoire dominates in peripheral D N T cells o f both patients and healthy individuals. The dominant expression o f Vc124 T C R was further examined by quantitative PCR. Vc~24 expression in patients showed a four-to fivefold increase compared with healthy donors (Fig. 3) . Together with the FACS | data, the results indicate that the number o f D N T cells, particularly Vo~24-bearing T cells, is higher in patients, although the TCR-oL repertoire in the D N population is restricted to Vc~24 in both SSc patients and healthy individuals.
Results and Discussion

Predominant Expansion of T C R
Oligoclonal Expansion of Vc~24 TCR in SSc Patients. Porcelli et al. (6) and Dellabona et al. (7, 8) Fig. 4 . In healthy individuals, invariant Vo~24Jc~Q T C R was dominant at a high frequency (6/11, 6/7, and 5/11). However, among 13 in-frame Vo~24 + c D N A clones in the patient SSc-1, four different Jo~ genes, IGRJci11, JciG, JciI, and JclAP511, were detected at a frequency o f 5/13, 4/13, 3/ 13, and 1/13, respectively. Although several distinct Vc~24 T C R were expressed, we noted clonal expansion ofinvariant VoL24 T C R other than Vc~24Jo~Q. Interestingly, the most dominant invariant Vc~24Jo~Q detected in healthy donors was not detected in patients. Similarly, in the patient SSc-2, 7 o f 12 clones represented the Vc124JoLV T C R , three clones used the JoLU gene, and two used the JccT gene. Again, we detected dominant expansion o f invariant VoL24Jo~V T C R different from Vc~24JclQ. In the patient SSc-3, seven different Jcl genes (JcxAA17, J~xT, IGRJoU1, IGRJoU0, Jo~AF211, Jo~U, and Jo~AP511) were used at frequencies of 1/15 to 5/15. Among them, invariant Vo~24 Jo~AA17 dominated, while no Vc~24JcxQ sequences were detected in the patient. Taken collectively, the VoL24 rep- cDNA (log) Figure 3 . Quantitative PCR analysis of V(x24 + TCR. The number of DN T cells isolated was normalized by counting cell numbers. Total RNA was extracted and used for PCR to measure the frequency of Vet24 § TCR. PCP, products were hybridized with 32p-labeled Ca probe, and the intensities of autographic bands were quantitated by a densitometer. The radioactivity of varying concentrations (corresponding to 0.01-10 pg DNA) of the standard Vet24 cDNA amplified by PCR. was compared with that of PCP, products from patients and healthy donors:
1, SSc-1; 2, SSc-2; 3, SSc-3; and 4, SSc-4 for SSc patients, and CI, C2, and C3 for healthy donors. The relative radioactivities of samples from four SSc patients are 67.9, 79.5, 89.5, and 93.1, respectively, all of which are significantly higher than the mean value of the control group (19.2 • 1.2; P <0.0005).
ertoire of DN c~/13 T cells in PBL was basically heterogeneous, but with apparent oligoclonal expansion ofinvariant Vo~24 TCR in both patients and healthy individuals. However, in healthy donors, invariant Vet24Jc~Q TCR always dominated, whereas, in SSc patients, invariant Vot24Je~Q TCI:k disappeared and oligoclonal expansion of other invariant Ve~24 TCR was observed.
Selective Loss of T Cells Bearing Invariant Vc~24JotQ TCR.
As shown in Fig. 4 , the invariant Ve~24Jo~Q TCR was found in healthy subjects at a high frequency (45-86% of total Ve~24 TCR), while it was not detected in SSc patients. To confirm the above findings, cDNA libraries generated by PCR were hybridized with the Vet24 probe and the Jo~Q probe. Frequencies of invariant vet24Je~Q TCR among total Vo~24 TCR sequences were estimated by the number of positive plaques and expressed as the ratio of invariant Vot24Je~Q to total Vot24. As shown in Table 1 , the invariant Ve~24Je~Q TCR was hardly detected in all SSc patients (0.4%, 0%, 0%), while it was expressed at a high frequency of 21-50% in healthy donors. Based on the calculation of actual cell number of DN e~/~ T cells, the number of T cells bearing invariant Vo~24J(xQ was in the range of 0--0.4/mm 3 in SSc patients and 6.9-12.5/mm 3 in the healthy donors (see Table 1 ). This indicates that the decrease in the expression of invariant Vet24JetQ TCR is due to the selective loss of T cells bearing invariant Vot24~otQ, and not to the relative increase in the number of Vet24 + T cells in SSc patients. The predominant expression of invariant Vcd4Jot281 TCR on the DN T cell population in the periphery has been reported in mice (18, 19) . The most characteristic feature of invariant Vet14 TCR with regard to autoimmune diseases is that there is a striking inverse correlation between autoimmune disease development and the expression of invariant Vet14 TCK. In fact, invariant Vot14 expression declines selectively with time after birth and disappears when mice develop autoimmune diseases in (NZB X NZW)F1, lpr, or gld mice (9) . Moreover, the treatment of young lpr mice with anti-Vex14 antibody in vivo induces splenomegaly at least threefold greater than that in untreated lpr mice at the same age, indicating the augmentation and acceleration of lymphoproliferative disorders. These results suggest that invariant Veal4 T cells function as regulatory T cells that control autoimmune disease development. Based on the above analogy to murine invariant Vot14 TCR, it is likely that human invariant vot24jtxQ TCR should play a decisive role in regulating the development ofautoimmune disease.
Contrary to the invariant Vct24JetQ TCR, DN et/[3 T cells in SSc patients showed oligoclonal expansion of invariant Vot24 TCR other than Vet24JotQ, including Vex24 IGRJot11, Vc~24JotG, VoL24JegV, and Vot24JetAA17 (Fig.  4) . Our previous studies have shown that the TCRV[3 repertoire in DN T cells is limited to one or two V[3 genes in an individual patient, such as V[35, V[37, or V[311 (15) . Because invariant Vtx24JotQ TCIL has been shown to be associated with skewed V[3, such as V132, V[38, V1311, and V[313 (6) (7) (8) 10) , the restricted V[3 usage that predominated in patients was different from that seen in healthy donors. In addition, these invariant Ve~24 TCR sequences were not detected in healthy individuals. Thus, they might be unique to SSc patients, suggesting that the expanded oligoclonal invariant Vot24 TCIL in SSc patients could be autoaggressive T cells in autoimmune status. Sequence differences in the oligoclonal Vot24 TCK that dominate in SSc patients might reflect differences in the polymorphism of restriction elements or in epitope specificities. The establishment ofT cells bearing invariant Vot24 TCR other than Ve~24JetQ from SSc patients will provide a clue to the mechanisms of autoimmune diseases.
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